Loading...
BVMFHAPV3
Market cap2.93bUSD
Dec 20, Last price  
2.38BRL
1D
3.93%
1Q
-45.03%
IPO
-91.40%
Name

Hapvida Participacoes e Investimentos SA

Chart & Performance

D1W1MN
BVMF:HAPV3 chart
P/E
—
P/S
0.65
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
17.44%
Rev. gr., 5y
43.02%
Revenues
27.38b
+15.30%
1,963,568,0002,459,008,0003,036,454,0003,847,981,0004,575,898,0005,634,383,0008,554,961,0009,883,385,00023,748,803,00027,383,408,000
Net income
-740m
L-4.65%
270,091,000301,238,000457,120,000648,768,000787,470,000849,825,000783,464,000497,795,000-775,839,000-739,769,000
CFO
931m
-4.22%
334,209,000356,868,000483,651,000618,548,000516,696,000656,779,0001,325,635,000212,410,000971,907,000930,868,000
Dividend
Dec 28, 20210.005372 BRL/sh
Earnings
Mar 26, 2025

Profile

Hapvida Participações e Investimentos S.A., together with its subsidiaries, operates in the health sector in Brazil. The company offers medical and dental insurance plans. It also provides medical and paramedical, laboratory, diagnostic, imaging, and ultrasound services, as well as organizes courses, lectures, seminars, and other events. In addition, the company engages in the administration, advisory, implementation, and sale of individual, family, and collective health care systems and plans; and reimbursement of medical, dental, hospital, and healthcare expenses to its beneficiaries, as well as provides medical and hospital care services. The company operates a network of 85 hospitals, 77 emergency units, 318 clinics, and 269 diagnostic units. The company was founded in 1979 and is based in Fortaleza, Brazil.
URL
https://ri.hapvida.com.br/
IPO date
Apr 25, 2018
Employees
Domiciled in
BR
Incorporated in
BR

Valuation

Title
BRL in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
27,383,408
15.30%
23,748,803
140.29%
9,883,385
15.53%
Cost of revenue
22,493,587
20,599,005
7,914,178
Unusual Expense (Income)
NOPBT
4,889,821
3,149,798
1,969,207
NOPBT Margin
17.86%
13.26%
19.92%
Operating Taxes
66,174
(671,970)
(7,460)
Tax Rate
1.35%
NOPAT
4,823,647
3,821,768
1,976,667
Net income
(739,769)
-4.65%
(775,839)
-255.86%
497,795
-36.46%
Dividends
(1,017,145)
(284,588)
Dividend yield
2.93%
0.71%
Proceeds from repurchase of equity
1,034,964
(126,861)
1,725,176
BB yield
-3.10%
0.37%
-4.32%
Debt
Debt current
2,585,120
2,077,794
770,285
Long-term debt
15,617,312
14,339,975
7,092,896
Deferred revenue
Other long-term liabilities
2,713,792
2,615,471
1,048,495
Net debt
8,074,818
11,818,113
5,795,901
Cash flow
Cash from operating activities
930,868
971,907
212,410
CAPEX
(168,266)
(735,991)
(708,076)
Cash from investing activities
(877,632)
2,099,888
(4,338,857)
Cash from financing activities
(1,278,109)
(2,151,136)
4,330,491
FCF
5,245,824
(472,032)
1,207,265
Balance
Cash
7,003,623
4,599,656
2,067,280
Long term investments
3,123,991
Excess cash
8,758,444
3,412,216
1,573,111
Stockholders' equity
49,545,525
37,841,243
8,125,038
Invested Capital
57,913,329
62,027,691
16,777,934
ROIC
8.04%
9.70%
15.34%
ROCE
7.07%
4.66%
10.39%
EV
Common stock shares outstanding
7,506,086
6,837,931
3,843,940
Price
4.45
-12.40%
5.08
-51.06%
10.38
-31.85%
Market cap
33,402,083
-3.84%
34,736,689
-12.94%
39,900,097
-29.48%
EV
41,478,270
46,562,076
45,696,851
EBITDA
7,018,337
5,337,081
2,864,292
EV/EBITDA
5.91
8.72
15.95
Interest
1,760,372
1,606,876
234,151
Interest/NOPBT
36.00%
51.02%
11.89%